Skip to main content
Call or Text: (914) 546-6571 Refer a Patient (for providers)
  • If you are in immediate danger, call 911
  • Suicide & Crisis Lifeline: call or text 988

Fast-acting, FDA-approved treatment for depression with suicidal ideation.

Spravato (esketamine) is FDA-approved specifically for major depressive disorder with acute suicidal ideation. It works within hours — not weeks. PMC Psychedelic offers this treatment in Port Chester, NY.

What this means, clinically.

Acute suicidal ideation refers to active thoughts of suicide or self-harm, often occurring alongside severe major depressive disorder. It is a medical emergency when immediate, and a serious clinical concern when persistent.
For many patients, suicidal thoughts are a symptom of undertreated or treatment-resistant depression — not a fixed state. When the underlying depression is treated effectively and quickly, these thoughts often diminish alongside it.
  • Spravato is specifically FDA-approved for MDD with acute suicidal ideation or behavior.
  • Rapid onset means meaningful relief can begin within hours of the first session.
  • Clinically supervised in our Port Chester clinic — every session monitored by our team.
  • Most PPO insurance plans cover this indication — we verify coverage in advance.

Why speed matters, and how Spravato delivers it.

Traditional antidepressants take 4 to 6 weeks to produce any measurable effect. For a patient experiencing acute suicidal ideation, that timeline is not acceptable.
Spravato works through the glutamate system — a different brain pathway entirely. This produces rapid changes in mood-regulating neural circuits. Many patients report meaningful relief within 24 hours of their first session.
  • FDA-approved specifically for MDD with acute suicidal ideation since 2020.
  • Nasal spray administered in-office — no IV required.
  • Monitored for a minimum of 2 hours after each session per FDA protocol.
  • Can be used alongside your existing oral antidepressant or as a standalone therapy.
  • Covered by most PPO insurance plans — we handle verification before your first visit.
Learn more about how Spravato works on our Spravato treatment page.

Important: PMC Psychedelic is not an emergency or crisis service.

If you or someone you know is in immediate danger, call 911 or go to your nearest emergency room.
For immediate emotional support, the 988 Suicide & Crisis Lifeline is available 24 hours a day, 7 days a week. Call or text 988.
PMC Psychedelic provides ongoing clinical treatment for patients with MDD and suicidal ideation who are medically stable and appropriate for outpatient care. Dr. Rueda evaluates every patient's suitability before treatment begins.

Who is a good candidate for this treatment?

Spravato for suicidal ideation is appropriate for adults with major depressive disorder who are experiencing active suicidal thoughts and have not found adequate relief through standard antidepressant treatment.
  • Adults 18 and older with a diagnosis of major depressive disorder.
  • Currently experiencing suicidal ideation or behavior.
  • Medically stable and appropriate for outpatient care — not requiring hospitalization.
  • Able to attend in-office sessions (approximately 2 hours each) and arrange a ride home.
  • Hold a PPO insurance plan, or prepared to pay out of pocket for Ketamine IV as an alternative.
Dr. Rueda personally evaluates every patient before treatment begins. Patient selection is central to how we practice. If Spravato is not the right fit, we will tell you — and discuss what alternatives may be appropriate.

Common questions.

Spravato is FDA-approved for this specific indication and has been studied in patients with active suicidal ideation. Every session at PMC is supervised by our clinical team. Dr. Rueda evaluates each patient before treatment begins to confirm they are appropriate for outpatient care. We do not treat patients who require hospitalization.

We aim to see new consultation requests as quickly as possible. Contact us directly to discuss urgency. If you or someone you know is in immediate danger, call 911 or 988 first.

Yes — Spravato is FDA-approved for MDD with acute suicidal ideation, and most PPO insurance plans cover this indication. We verify your coverage before your first appointment. Call us to begin the verification process.

In most cases, yes. Spravato is approved for use alongside an oral antidepressant. Dr. Rueda will review your full medication list during your evaluation and advise accordingly.

More questions? Visit our full FAQ page or call us directly.
Get Started

You deserve treatment that acts quickly.

Request a consult with Dr. Rueda's team. We will review your situation, verify your insurance, and determine the right treatment path for you.
If you are in immediate distress, please call 988 (Suicide & Crisis Lifeline) or 911 before booking.
PMC Psychedelic · Port Chester, NY · Serving Westchester & Fairfield County
© 2026 PMC Psychedelic Medicine Centers of America. All rights reserved.